Stock 6535 LUMOSA THERAPEUTICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Lumosa Therapeutics Co., Ltd.

Equities

6535

TW0006535008

End-of-day quote Taipei Exchange
Other stock markets
 18:00:00 2024-05-30 EDT 		5-day change 1st Jan Change
180 TWD -4.00% Intraday chart for Lumosa Therapeutics Co., Ltd. -1.10% +163.54%
05-14 Lumosa Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-14 Lumosa Therapeutics Co., Ltd. Announces the Change of Chairperson CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Lumosa Therapeutics Co., Ltd. Announces the Change of Chairperson
CI
Lumosa Therapeutics Co., Ltd. Announces the Change in Juristic-Person Director Representative
CI
Lumosa Therapeutics Co., Ltd. Appoints Hsin-Jung Lin as Member of the Audit Committee
CI
Lumosa Therapeutics Co., Ltd. Announces Appointment of Hsin-Jung Lin as Independent Director
CI
Lumosa Therapeutics Co., Ltd. Appoints Lanying Huang as Corporate Governance Officer
CI
Lumosa Approves Management Changes, Effective February 1, 2022
CI
Lumosa Therapeutics Co., Ltd. Announces Board Changes
CI
Lumosa Therapeutics Co., Ltd. Announces Compensation Committee Changes
CI
Lumosa Therapeutics Co., Ltd. Appoints Members to Audit Committee
CI
Lumosa Therapeutics Co., Ltd. Announces Chairman Changes
CI
Lumosa Therapeutics Co., Ltd. Announces Resignation of Ya-Ting Hsu as Chief Internal Auditor, Effective March 31, 2021
CI
Lumosa Therapeutics Co., Ltd. Announces By-Election of Chih-Yung Chin as Independent Director
CI
Lumosa Therapeutics Co., Ltd. Announces Resignation of Wendy Wen-Ing as Chief Strategic Officer, Effective March 4, 2019
CI
Lumosa Therapeutics Co., Ltd. Announces Resignation of Shengwan Lee, Independent Director, as a Member of the Compensation Committee
CI
Lumosa Therapeutics Co., Ltd. Appoints Huang, Wendy Wen-Ing as Chief Strategic Officer
CI
Lumosa Therapeutics Board Approves Appointment of Pei-Jiun Chen as Chief Operating Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6535 Stock
  4. News Lumosa Therapeutics Co., Ltd.
  5. Insiders